A class action filed this month in California alleges that Bhang
Corporation, a Florida-based medicinal chocolate maker, violated
several state and federal laws by claiming that its chocolate
products contained much greater amounts of tetrahydrocannabinol
("THC") and cannabidiol ("CBD") than they
actually did, in order to charge consumers premium prices.
The complaint alleges that plaintiff Charles Ballard purchased
Bhang Medicinal Chocolates from 2016 to 2018, which contained
allegedly false, deceptive, and/or misleading product labels as to
the amounts and/or levels of THC and/or CBD in the products.
Independent lab testing commissioned by the plaintiff revealed that
the amounts and/or levels of THC and CBD in the chocolate products
were substantially less than as stated on the packaging and
marketing materials.
